R&Dplatform

联系我们

国际针灸合作委员会关于变更办公地址的通知

中国民间中医医药研究开发协会国际针灸合作委员会

办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,

同时为方便大家联系,固定电话已经变更

新号码010—58562339。特此通知。

地址:北京西城区西直门南小街国英园一号楼824室

邮编:100035

电话:010-58562339

传真:010-58562339

邮箱:cngjzj@163.com

网站(点击网址直接链接↓):http://www.cngjzj.com/

博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj

交通路线图 (点击观看大图)

到西城区西直门南小街国英园一号楼行驶路线

机场线路1

从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:

1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

机场线路2

从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。

附近公交地铁:

公交官园站:107路,运通106路

公交西直门南:387路,44路,800内环,816路,820内环,845路

地铁车公庄:地铁二号线

地铁西直门:地铁二号线

公交车公庄东:107路,118路,701路

公交车公庄北:209路,375路,392路

您现在的位置是: 首页 >> R&Dplatform >> R&Dplatform

Chinese medicine has been listed in the United States pharmacopoeia

2014年09月03日

复制链接 打印 大 中 小

<

 

 

 

Chinese medicine has been listed in the United States pharmacopoeia 
 
 
The 2014-09-01
 
 
Source: the old man (guangzhou) 

 

 

        A few days ago, China's traditional Chinese medicine academy of sciences, said zhang bl, China has listed in the United States pharmacopoeia standards of traditional Chinese medicines, there are dozens of drugs is a review by the United States pharmacopoeia committee, estimates that in recent years within the United States pharmacopoeia will have income. 
 
        Zhang bl, points out that China's major projects and also very concerned about Chinese traditional medicine new drug research and development and internationalization of traditional Chinese medicine research work. Especially to support the study on Chinese traditional medicine new drug registration in Europe and America, which is in accordance with the standards of European and American countries for the clinical evaluation of Chinese medicine, this piece of work in the United States nearly seven drugs are now conducting clinical research. Among them, compound danshen dropping pill, :, centralizer blood capsule three drugs has completed the second phase of clinical research, have been carried out the study of clinical phase iii. 
 
        Cassia twig tuckahoe capsule in clinical phase ii study, progress more smoothly. At the same time, registered in the eu also carried out the study, in which mondial has completed the registration work, effort is ongoing, there are several drugs is expected to close within a year or two will also be a registered success. 
 
        Bo-li zhang stressed that the Chinese medicine pharmacopoeia standards in the United States, they will also plant medicine according to the requirements of this standard, provides the basis to us more medicine to enter the United States. In general, the major projects, to the modernization of traditional Chinese medicine (TCM) to actively promote the internationalization of Chinese medicine, has also made certain progress.
 
 
(China)